Investigating how a specific gene affects smooth muscle cells in heart disease.
Official title: The role of Twist1 in SMC phenotypic modulation during atherosclerosis
Funded at Univ of North Carolina Chapel Hill · NIH-10989901 · Data updated 2026-11-12
This study is looking at how a gene called Twist1 affects smooth muscle cells in your arteries as they change during atherosclerosis, which can lead to heart disease, to find new ways to help keep your heart healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | December 1, 2023 |
| Project end | November 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $465,968 |
| NIH project number | 5R01HL171275-02 |
| Project ID | NIH-10989901 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for atherosclerosis or those with existing cardiovascular conditions.
✕Less likely to help
Patients without cardiovascular risk factors or those with non-atherosclerotic conditions may not benefit from this research.
What this research studies
This research focuses on understanding the role of a gene called Twist1 in the behavior of smooth muscle cells (SMCs) during the development of atherosclerosis, a condition that can lead to heart disease. By using advanced techniques like single cell RNA sequencing, the researchers aim to observe how SMCs change their characteristics and contribute to the formation of arterial plaques. The study will explore how these changes can influence disease progression and risk factors associated with coronary artery disease. Ultimately, the goal is to identify potential therapeutic targets that could improve heart health.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce the risk of heart disease by targeting specific cellular processes.
How similar studies have gone: Previous research has shown promising results in understanding the genetic factors influencing atherosclerosis, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Wirka, Robert — Univ of North Carolina Chapel Hill
- Study coordinator: Wirka, Robert
Related research
Other NIH-funded projects on the same topics.
-
Coronary disease and immune activation in people with HIV and tuberculosis coinfection
This research looks at how having HIV and latent tuberculosis together might raise the risk of heart disease, and what immune changes are involved.
-
PFAS may speed up artery disease by changing bile acids
Aims to see if PFAS chemicals make cholesterol rise and arteries more likely to harden, using a human-similar mouse model to understand how this could affect people.
-
IgE antibodies to alpha-gal and heart disease in mice and people
A study to understand how specific IgE antibodies against alpha-gal might influence the development and severity of atherosclerosis in humans and mouse models.
-
Fibroblast Growth Factor 1 to Reduce High Lipids and Plaque in Adults with Diabetes
A new approach uses a modified FGF1 protein to lower bad cholesterol and prevent artery plaque buildup in adults with Type 2 diabetes, aiming for safer and more effective treatment.
-
Atherosclerosis in cocaine addiction: imaging risk with PET/MR
This project uses PET/MR imaging to look for early artery disease in people with cocaine use disorder to help prevent strokes or other brain injuries.
-
How low blood flow after brain artery narrowing affects the vessel lining
This work looks at whether areas of low blood flow downstream of narrowed brain arteries cause vessel lining damage and raise the chance of another stroke, for people with intracranial artery narrowing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.